Viewing Study NCT04564768


Ignite Creation Date: 2025-12-24 @ 5:47 PM
Ignite Modification Date: 2025-12-28 @ 12:40 AM
Study NCT ID: NCT04564768
Status: COMPLETED
Last Update Posted: 2022-11-29
First Post: 2020-08-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: The SERENITY Study: Online Mindfulness-Based Cancer Recovery for Patients With Gynecological Cancer
Sponsor: University Hospital, Geneva
Organization:

Study Overview

Official Title: Online Mindfulness-Based Cancer Recovery (MBCR) Program for Patients Living With a Gynecological Cancer: a Pilot Randomized Controlled Study.
Status: COMPLETED
Status Verified Date: 2022-11
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: SERENITY
Brief Summary: The overall objective of this project is to explore the feasibility, acceptability and potential effects of the online MBCR program in gynecological cancer settings. This will provide preliminary efficacy data in prevision of a larger, confirmatory, randomized controlled trial. As this study will be one of the first led in a French speaking country and the first conducted in a university hospital environment in Switzerland, the investigators would like to investigate the early implementation of this program among professionals and patients. Furthermore, they will investigate if in the online MBCR group, participants will show improvement in psychosocial outcomes, consumption of psychotropic and opioid medication, spirituality and meaning in life and in different biological processes.
Detailed Description: None

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: